Sanigen Co., Ltd. (188260) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sanigen Co., Ltd. (188260:KRX), powered by AI.

Current Price
₩1,623
P/E Ratio
-3.7
Market Cap
21.5B
Sector
Healthcare
What is the Sanigen Co., Ltd. stock price forecast?

Sanigen Co., Ltd. is currently trading at ₩1,623. View real-time AI analysis on Alpha Lenz.

What is Sanigen Co., Ltd. insider trading activity?

View the latest insider trading data for Sanigen Co., Ltd. on Alpha Lenz.

What is Sanigen Co., Ltd.'s P/E ratio?

Sanigen Co., Ltd.'s P/E ratio is -3.7.

Sanigen Co., Ltd.

KRX · 188260
₩1,623-7(-0.43%)Market closedKRX regular session 09:00–15:30 KST
Ask about Sanigen Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Sanigen Co., Ltd. trades at a P/E of -3.7 (undervalued) with modest ROE of -108.6%.

Ask for details

Company Overview

Sanigen Co., Ltd. is a specialized biotechnology company known for its innovative solutions in the fields of molecular diagnostics and advanced genetic research. With a particular focus on the development of diagnostic kits and services, Sanigen aims to enhance the early detection and management of diseases through cutting-edge technologies. The company leverages its extensive expertise in next-generation sequencing and bioinformatics to offer comprehensive genomic profiling, which is crucial for personalized medicine and research. Sanigen's products and services serve various sectors, including healthcare, pharmaceuticals, and academic research, providing tools that aid in understanding genetic factors and disease mechanisms. As a key player in the biotechnology industry, Sanigen Co., Ltd. contributes significantly to advancements in medical diagnostics and personalized treatment strategies, positioning itself as a pivotal entity in the evolving landscape of healthcare and genetic research.

CEO박정웅
SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

₩21,526,616,679Market Cap
₩15,354,255,260Revenue
13.26MShares Out
0Employees

Margins

20.25%Gross
-28.31%EBITDA
-28.49%Operating
-38.00%Pre-Tax
-37.91%Net

Valuation

-3.70P/E
8.69P/B
1.40EV/Sales
-5.18EV/EBITDA
-4.90P/FCF

Growth (CAGR)

-16.90%Rev 3Yr
-8.15%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-46.94%ROA
-108.63%ROE
-45.87%ROIC

Financial Health

₩1,582,759,000Cash & Cash Equivalents
₩6,052,365,270Net Debt
308.28%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Sanigen Co., Ltd. (ticker: 188260) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $21.5B.

The current price is ₩1,623 with a P/E ratio of -3.7x and P/B of 8.69x.

ROE is -108.63% and operating margin is -28.49%. Annual revenue is $15.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Sanigen Co., Ltd. (188260) Stock Forecast 2026 ₩1,623 — Price, Financials & Analyst Targets | Alpha Lenz